Your browser doesn't support javascript.
loading
Erratum: preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.
Hendlisz, Alain; Golfinopoulos, Vassilis; Deleporte, Amelie; Paesmans, Marianne; El Mansy, Hazem; Garcia, Camilo; Peeters, Marc; Annemans, Lieven; Vandeputte, Caroline; Maetens, Marion; Van den Eynde, Marc; Maréchal, Raphaël; Borbath, Ivan; Dresse, Damien; Houbiers, Ghislain; Fried, Michael; Awada, Ahmad; Piccart, Martine; Van Laethem, Jean-Luc; Flamen, Patrick.
Afiliación
  • Hendlisz A; Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. alain.hendlisz@bordet.be.
  • Golfinopoulos V; Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. vassilis.golfinopoulos@gmail.com.
  • Deleporte A; Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. amelie.deleporte@bordet.be.
  • Paesmans M; Data Center, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. marianne.paesmans@bordet.be.
  • El Mansy H; Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. hazem.elmansy@bordet.be.
  • Garcia C; Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. camilo.garcia@bordet.be.
  • Peeters M; Department of Oncology, Antwerp University Hospital, Antwerp, Belgium. Marc.Peeters@uza.be.
  • Annemans L; Health Economics, Department of Public Health, Ghent University, Ghent, Belgium. Lieven.Annemans@UGent.be.
  • Vandeputte C; Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. caroline.vandeputte@bordet.be.
  • Maetens M; Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. marion.maetens@bordet.be.
  • Van den Eynde M; Gastroenterology Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. marc.vandeneynde@uclouvain.be.
  • Maréchal R; Gastroenterology Department, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium. raphael_marechal@erasme.ulb.ac.be.
  • Borbath I; Gastroenterology Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium. ivan.borbath@uclouvain.be.
  • Dresse D; Service de Chirurgie Abdominale et Générale, Centre Hospitalier Régional La Citadelle, Liège, Belgium. damien.dresse@chrcitadelle.be.
  • Houbiers G; Service d'Oncologie et d'Hématologie, CH Saint Joseph, Liège, Belgium. ghislain.houbiers@gmail.com.
  • Fried M; Oncology department, Ziekenhuis Netwerk Antwerpen, Antwerpen, Belgium. michael.fried@zna.be.
  • Awada A; Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. ahmad.awada@bordet.be.
  • Piccart M; Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. martine.piccart@bordet.be.
  • Van Laethem JL; Gastroenterology Department, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium. jvlaethe@ulb.ac.be.
  • Flamen P; Nuclear Medicine Department, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. patrick.flamen@bordet.be.
BMC Cancer ; 15: 173, 2015 Mar 25.
Article en En | MEDLINE | ID: mdl-25879441

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Bélgica